Texas Halo Fund

Texas Halo Fund is a venture capital firm based in Houston, Texas, established in 2012. The firm focuses on investing in early-stage businesses with strong growth potential and capable management teams. Texas Halo Fund seeks to identify compelling investment opportunities across various industries and geographic locations, prioritizing those that exhibit promising prospects. Its investment strategy includes a preference for sectors such as healthcare and information technology, while also considering businesses in the software sector. The firm aims to generate high returns for its investors while minimizing risk, typically investing with a horizon of five to seven years.

Andrew Clark

Founder

Kyra Doolan

Managing Director, Funds II, III and IV

Kevin King

Managing Director

Christy Luquire

Managing Director

Christina Luquire

Managing Director and Fund I Deal Committee Member

David Steakley

Managing Director

Bill Wheelock

Managing Director

Past deals in Texas

Dynamic Light

Convertible Note in 2022
Dynamic Light, established in May 2018 and based in Austin, Texas, specializes in advanced blood flow imaging technology aimed at enhancing patient care and reducing healthcare costs. The company’s innovative solution enables real-time, continuous, and quantitative visualization of blood flow in living tissues, allowing surgeons to make informed decisions during procedures. By providing high-resolution imaging without the need for dyes or procedural interruptions, Dynamic Light's technology supports improved surgical outcomes and patient management.

Resonant Therapeutics

Series A in 2021
Resonant Therapeutics, Inc. is a biotechnology company based in Houston, Texas, founded in 2014. The company operates a proprietary discovery platform known as the Integrated Microenvironment Pathway Catalog and Triage (IMPaCT), which facilitates the rapid and simultaneous identification of novel therapeutic targets and high-affinity, functional antibodies. By leveraging insights into the tumor microenvironment and the immune system, Resonant Therapeutics' platform can analyze patient-derived tumor tissues or cell lines, including cancer stem cells, to uncover potential therapeutic candidates. The company's research initially focuses on breast and ovarian cancers, developing antibodies that demonstrate potent anti-tumor activity. These antibodies are designed to function effectively as standalone treatments or in combination with newer immunotherapies. Resonant Therapeutics has established a strategic alliance with Retrogenix Ltd. to enhance its drug discovery capabilities.

WorkEQ

Seed Round in 2021
WorkEQ is a business development and employment agency focused on enhancing workplace flexibility and productivity. The company has developed a contact tracing and health monitoring platform that aims to protect employees from infectious diseases. This platform provides immediate access to critical data regarding the onset of symptoms, allowing organizations to identify the infectious period and potential exposure among staff. By enabling swift and effective responses to health concerns, WorkEQ seeks to foster a safer work environment, ultimately improving employee engagement and promoting a more inclusive workplace culture.

Work & Mother

Convertible Note in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Ictero Medical

Convertible Note in 2021
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

Galen Data

Series A in 2021
Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Work & Mother

Pre Seed Round in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Ikonopedia

Series D in 2021
Ikonopedia, LLC specializes in creating a cloud-based breast study interpretation and reporting system tailored for radiologists. The company offers a Mammography Reporting System that includes screening and diagnostic modalities, generating structured reports compliant with the Mammography Quality Standards Act. Additionally, it provides SonoPro, a web application designed to assist radiologists in interpreting diagnostic breast ultrasound exams. Ikonopedia's solutions enhance workflow efficiency and are utilized in telemammography and satellite clinics. The system features automated patient tracking, ensuring compliance with the ACR BI-RADS® Atlas 5th Edition and monitoring patients through all stages of the exam process. By providing clear and consistent clinical reports, Ikonopedia aims to improve patient safety and streamline operations for radiologists and their staff. Founded in 2012 and headquartered in Dallas, Texas, Ikonopedia addresses critical needs in breast radiology, ultimately contributing to better health outcomes for women.

VenoStent

Seed Round in 2021
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Allotrope Medical

Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Your Fare

Convertible Note in 2021
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

ImmunoGenesis

Venture Round in 2020
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

SIERA.AI

Series A in 2020
SIERA.AI specializes in providing software-as-a-service (SaaS) solutions for industrial vehicle inspections and offers Internet of Things (IoT) driver assistance technology aimed at enhancing safety and productivity. The company delivers a data-driven dashboard that allows enterprises to monitor individual drivers, thereby managing risk and improving operational efficiency. SIERA.AI's after-market middleware technology is compatible with various brands and models, enabling seamless integration with leading global manufacturers. Founded in 2017 and based in Austin, Texas, SIERA.AI is committed to advancing the capabilities of automated material handling through innovative technology.

TrueSpot

Seed Round in 2020
Developer of an Internet of Things asset location platform designed to manage automotive dealership inventory. The company's platform offers real-time location services and accelerates the speed of a costly, highly dispersed auto-reconditioning process, enabling dealers to find, track and map critical assets and processes.

Allotrope Medical

Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Your Fare

Convertible Note in 2020
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

VenoStent

Seed Round in 2020
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Galen Data

Seed Round in 2019
Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Zibrio

Convertible Note in 2019
Zibrio is a balance diagnostics company based in Houston, Texas, founded in 2017. The company has developed a unique biometrics device that utilizes advanced knowledge of postural control and machine learning to detect subtle changes in balance. Originally based on technology developed for NASA to assess astronauts' stability post-spaceflight, Zibrio's technology aims to empower users to monitor and improve their health. The device provides insights into individual balance profiles, offering assistance and advice to enhance stability, reduce the risk of falls, and promote overall well-being. Through its innovative approach, Zibrio seeks to advance the understanding of balance and contribute to better health outcomes for its users.

Allotrope Medical

Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

VenoStent

Pre Seed Round in 2019
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Ictero Medical

Convertible Note in 2019
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

SIERA.AI

Seed Round in 2019
SIERA.AI specializes in providing software-as-a-service (SaaS) solutions for industrial vehicle inspections and offers Internet of Things (IoT) driver assistance technology aimed at enhancing safety and productivity. The company delivers a data-driven dashboard that allows enterprises to monitor individual drivers, thereby managing risk and improving operational efficiency. SIERA.AI's after-market middleware technology is compatible with various brands and models, enabling seamless integration with leading global manufacturers. Founded in 2017 and based in Austin, Texas, SIERA.AI is committed to advancing the capabilities of automated material handling through innovative technology.

Ikonopedia

Series C in 2019
Ikonopedia, LLC specializes in creating a cloud-based breast study interpretation and reporting system tailored for radiologists. The company offers a Mammography Reporting System that includes screening and diagnostic modalities, generating structured reports compliant with the Mammography Quality Standards Act. Additionally, it provides SonoPro, a web application designed to assist radiologists in interpreting diagnostic breast ultrasound exams. Ikonopedia's solutions enhance workflow efficiency and are utilized in telemammography and satellite clinics. The system features automated patient tracking, ensuring compliance with the ACR BI-RADS® Atlas 5th Edition and monitoring patients through all stages of the exam process. By providing clear and consistent clinical reports, Ikonopedia aims to improve patient safety and streamline operations for radiologists and their staff. Founded in 2012 and headquartered in Dallas, Texas, Ikonopedia addresses critical needs in breast radiology, ultimately contributing to better health outcomes for women.

MacroFab

Series A in 2019
MacroFab is a marketplace for electronics manufacturing from prototype to high scale production. Their platform is re-shaping the $480B contract manufacturing market by transforming the experience from a manual, time-intensive, and error-prone process performed by large teams of people, into a real-time, streamlined, and connected software-driven experience while providing access to unlimited factory capacity in North America. The platform also uploads a PCB board design, gets an instant quote and the board is printed in the company's factory, enabling startups, manufacturers, and enterprises to design, customize and automate the PCB manufacturing process and save time, effort and money. Macrofab was founded in 2013 and is headquartered in Houston, Texas, United States.

TeVido BioDevices

Venture Round in 2019
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing tissue-engineered products for reconstructive surgery. Established in 2016, the company leverages 3D bio-printing technology and patients' living cells to create custom grafts tailored to individual needs. TeVido's innovative approach aims to enhance options for breast cancer survivors and others experiencing disfigurement, ultimately improving self-esteem and quality of life. In addition to its primary focus on breast reconstruction, TeVido's technology is applicable to a broad range of needs in wound healing and cosmetic surgery, addressing various unmet demands in these fields. The company's advancements in cellular therapy and manufacturing techniques enable the restoration of lost skin color, offering significant improvements in surgical outcomes.

ClearCam

Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. The company specializes in manufacturing a laparoscopic lens cleaner device known as ClearCam Kelling, which is designed to enhance the visual field for surgeons during laparoscopic procedures. This innovative device allows for intra-operative lens cleaning without the need to remove the laparoscope from the body cavity, thereby streamlining surgical processes and improving safety. By eliminating the requirement for additional supplies, ClearCam's technology contributes to reduced procedure time, benefiting patients, surgeons, and surgical staff alike.

TeVido BioDevices

Seed Round in 2018
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing tissue-engineered products for reconstructive surgery. Established in 2016, the company leverages 3D bio-printing technology and patients' living cells to create custom grafts tailored to individual needs. TeVido's innovative approach aims to enhance options for breast cancer survivors and others experiencing disfigurement, ultimately improving self-esteem and quality of life. In addition to its primary focus on breast reconstruction, TeVido's technology is applicable to a broad range of needs in wound healing and cosmetic surgery, addressing various unmet demands in these fields. The company's advancements in cellular therapy and manufacturing techniques enable the restoration of lost skin color, offering significant improvements in surgical outcomes.

Your Fare

Seed Round in 2018
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

VenoStent

Pre Seed Round in 2018
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Riders Share

Seed Round in 2018
Riders Share is a peer-to-peer marketplace that specializes in street-legal motorcycle rentals. The platform allows motorcycle owners to list their bikes, enabling riders to choose from a wide variety of options, from low-capacity models to high-end custom motorcycles. This service simplifies the rental process, eliminating the hassles associated with traditional rental companies. Riders Share operates in major cities across the United States, including Los Angeles, New York, and Miami, offering a diverse inventory of over 2,000 motorcycles, making it the largest source for motorcycle rentals in the country. The company also prioritizes safety by screening potential renters and providing insurance, which fosters a trustworthy environment for both renters and bike owners.

Glycos Biotechnologies

Seed Round in 2018
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.

SIERA.AI

Pre Seed Round in 2018
SIERA.AI specializes in providing software-as-a-service (SaaS) solutions for industrial vehicle inspections and offers Internet of Things (IoT) driver assistance technology aimed at enhancing safety and productivity. The company delivers a data-driven dashboard that allows enterprises to monitor individual drivers, thereby managing risk and improving operational efficiency. SIERA.AI's after-market middleware technology is compatible with various brands and models, enabling seamless integration with leading global manufacturers. Founded in 2017 and based in Austin, Texas, SIERA.AI is committed to advancing the capabilities of automated material handling through innovative technology.

Infrastructure Networks

Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.

DNAtrix

Convertible Note in 2016
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

Onit

Venture Round in 2016
Onit, Inc. specializes in developing legal project management and workflow automation software designed to enhance productivity and streamline operations across various business departments. The company's offerings include Enterprise Legal Management, Matter Management, Legal Spend Management, Contract Lifecycle Management, and Legal Holds, which collectively facilitate the efficient handling of legal matters and spending. Additionally, Onit provides a self-service portal for Legal Service Requests and tools like Apptitude for workflow automation and Precedent, an artificial intelligence platform. By allowing users to create custom applications without reliance on IT support, Onit simplifies business processes that are typically manual and cumbersome. Founded in 2011 and headquartered in Houston, Texas, with additional offices in Austin, Auckland, and Pune, Onit serves a diverse range of industries, including technology, insurance, healthcare, and finance, helping clients to automate processes, reduce costs, and maximize productivity.

Adient Medical

Series C in 2016
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.

Adient Medical

Seed Round in 2015
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.

HUVRData

Seed Round in 2015
HUVRData, LLC specializes in developing enterprise asset management software designed to enhance return on investment for asset owners through digital maintenance and inspection workflows. The company's offerings include InspectFlow, a platform for digitizing inspection checklists; ImageFlow, which processes inspection images and allows for tagging and annotating damage; and Anytime / Anywhere Forms, enabling field inspectors to document issues in real-time. Additionally, HUVRData provides a central control panel for asset management, a reporting tool for various formats, and an analytics engine that delivers actionable insights and trend analysis. The firm serves a diverse clientele, including asset owners and service providers in the renewables, oil and gas, maritime, and utility sectors, catering to Fortune 500 companies across multiple industries. Founded in 2014 and based in Austin, Texas, HUVRData focuses on facilitating digital transformation and breaking down data silos within enterprise asset management.

Set.fm

Convertible Note in 2015
Set.fm, Inc. is an online platform based in Austin, Texas, that enables live concert performers to capture and sell recordings of their performances immediately after the show. Founded in 2012 and formerly known as DejaSet, Inc., Set.fm provides a user-friendly mobile application that allows musicians to easily record high-quality audio using existing equipment. This innovative service allows artists to tap into new revenue streams by promoting and selling their live recordings directly to fans, who can purchase copies of performances before leaving the venue. As a subsidiary of VNUE, Inc., Set.fm is committed to enhancing the live music experience for both performers and audiences.

DNAtrix

Series B in 2014
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

Siotex

Seed Round in 2014
SioTeX Corporation, established in 2014 and based in San Marcos, Texas, specializes in the manufacture of specialty chemicals and performance materials. The company has developed Eco-Sil, a sustainable and efficient drop-in replacement for fumed silica, utilizing rice hulls—a widely available biowaste—as its primary raw material. This innovative approach not only simplifies the production process significantly but also reduces energy consumption and minimizes the use of toxic reactants compared to traditional methods. SioTeX's technology addresses the environmental issue of rice hull waste, which is often discarded in landfills or burned in the fields, and has gained recognition for its contributions to waste reduction, including an award from the Environmental Protection Agency.

Deep Imaging Technologies

Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company based in Tomball, Texas, that specializes in developing advanced data collection equipment and software for the oil and gas industry. Founded in 2008, the company focuses on creating surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively visualize geological features. Its portfolio includes transmitters, receivers, and software designed for processing and imaging, enabling clients to better understand subsurface conditions.

Quarri

Series C in 2013
Quarri Technologies, Inc. specializes in developing web security software aimed at safeguarding endpoints and sensitive data for organizations. Its key offerings include Perimeter Shield, which protects web applications from malware and network attacks; Data Safe, which controls and secures browser-delivered information; and Armored Browser, designed to defend Windows systems against web-borne malware. Additionally, Quarri provides MyPOQ, a secure web browser for various devices, along with solutions for online banking security, PCI compliance, cloud application security, and intellectual property protection. The company serves clients across North America, Europe, and the Middle East, enabling enterprises to implement security measures for web applications and prevent data leakage regardless of the user's location. Quarri Technologies, originally founded as Quaresso Software Technologies in 2007, is based in Austin, Texas, but filed for liquidation in December 2017.

Cinegif

Seed Round in 2013
Cinegif is an Austin, Texas-based software development company whose patented video conversion software helps marketers communicate and tell a story, without the file size, complexity, and cost of traditional video. Branding professionals, email marketing firms, and web hosting companies use Cinegifs to improve customer engagement on web pages, e-mail, social media, text messages, and digital signage.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.